StonvexLoading…
StonvexStonvexStonvexCore line items from MDLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $28.43B | $25.51B | $23.23B |
Operating Income | $2.21B | $2.15B | $1.25B |
Net Income | $1.16B | $1.16B | $234.00M |
EPS (Diluted) | $-0.01 | Not available | Not available |
Total Assets | $38.48B | $35.98B | Not available |
Total Liabilities | $19.20B | $19.45B | Not available |
Cash & Equivalents | $1.94B | $199.00M | $1.58B |
Free Cash Flow OCF − CapEx | $1.30B | $1.42B | $1.41B |
Shares Outstanding | 810.00M | Not available | Not available |